Mutations in the STAT3 and STAT5b genes can be used as molecular markers for T-LGLL diagnostics [36], but their prevalence in FS and their diagnostic value for the differential diagnosis between FS and RA-associated T-LGLL remain unclear. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.